TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - NOVO-NORDISK B TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - NOVO-NORDISK B Stock
Certificat
DE000SW7G8G7
| Market Closed - Boerse Frankfurt Warrants 15:51:41 2024-07-05 EDT | ||
| 3.15 EUR | -2.48% |
|
| Current month | +10.60% | ||
| 1 month | -3.69% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 3.13 | -3.10% |
| 24-07-04 | 3.23 | -2.71% |
| 24-07-03 | 3.32 | +12.93% |
| 24-07-02 | 2.94 | +8.89% |
| 24-07-01 | 2.7 | -4.59% |
Real-time Boerse Frankfurt Warrants
Last update July 05, 2024 at 03:51 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | NOVO NORDISK A/S |
| Issuer | 
Société Générale
|
| WKN | SW7G8G |
| ISIN | DE000SW7G8G7 |
| Date issued | 2024-03-11 |
| Strike | 1,210 kr |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.99 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.1 € |
|---|---|
| Lowest since issue | 2.45 € |
| Spread | 0.07 € |
| Spread % | 2.17% |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
974
DKK
Average target price
952.2
DKK
Spread / Average Target
-2.24%
- Stock Market
- Certificates
- Certificat
